Construction Begins! A New Engine Powers Bincheng's Health Industry
On June 27, the groundbreaking ceremony for the "Continuous Glucose Monitoring System Production Workshop Project" of Tianjin Empecs Medical Device Co., Ltd. was held in Zhaishang Street, Binhai New Area.
Tianjin Empecs Medical Device Co., Ltd., a Korean-funded enterprise, has created more than 1,000 jobs in the region since its establishment in 1992. Its independently developed blood glucose meters and other products have obtained technical patents in China, South Korea, the United States, and other countries, and are sold in both domestic and international markets. The company is investing 30 million yuan to develop and produce an embedded continuous glucose monitoring system (CGMS ), which enables real- time monitoring of blood glucose fluctuations in diabetic patients, helping them formulate more effective blood glucose management plans. The facility is expected to produce 100,000 units annually, with an annual output value of 50 million yuan.
Yang Hongyuan, Deputy Director of the Zhaishang Subdistrict Office, said , “Tianjin Empecs Medical Device’ s investment of 30 million yuan for capital increase and expansion is a strategic move to deepen its presence in the Bincheng market. This will generate significant benefits for the jurisdiction in terms of tax revenue, job creation, and economic growth. Zhaishang Subdistrict will continue to provide high- quality business services, offer comprehensive support to enterprises, and follow up closely throughout the entire process — from project construction to completion and production. With more pragmatic measures, we are committed to creating a favorable environment that enables enterprises to take root and thrive in Bincheng Zhaishang.”
In recent years, Zhaishang Subdistrict has continuously optimized its business environment, cultivated a fertile industrial ecosystem, and achieved remarkable results. As a key foreign-funded and national high- tech enterprise within the jurisdiction, Tianjin Empecs Medical Device Co., Ltd. has made outstanding contributions to strengthening the tax base and enhancing employment opportunities in the region. In 2024, the company became a pillar of the local economy, recording an annual output value of over 400 million yuan and tax contributions exceeding 14 million yuan. In 2025, the company will further expand its footprint with the official launch of the "Continuous Glucose Monitoring System" R&D and production project, backed by an investment of 30 million yuan. This project marks a significant step toward the high-quality development of the advanced manufacturing sector within the jurisdiction.
In the future, Zhaishang Subdistrict will adopt more pragmatic measures, focus on meeting the needs of all aspects of project development, continuously optimize the business environment, and provide enterprises with more considerate and efficient services. The goal is to create a new benchmark for a business ecosystem that attracts talent and investment from both near and far.